D. Maisel

发表

Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping

J. Dudley, A. Bauer-Mehren, Wei-Yi Cheng, 2017, Cancer Epidemiology, Biomarkers & Prevention.

An integer linear programming approach for finding deregulated subgraphs in regulatory networks

Christina Backes, Eckart Meese, Andreas Keller, 2011, Nucleic acids research.

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

E. Voss, D. Maisel, M. Klammer, 2012, Cancer research.

The Roche Cancer Genome Database 2.0

Hans-Peter Lenhof, D. Maisel, S. Klostermann, 2011, BMC Medical Genomics.

Imaging , Diagnosis , Prognosis Blood-Based Gene Expression Signatures in Non – Small Cell Lung Cancer

Roman K. Thomas, T. Zander, W. Engel-Riedel, 2011 .

Intracellular proteins displayed on the surface of tumor cells as targets for therapeutic intervention with antibody-related agents.

U. Weidle, D. Maisel, S. Klostermann, 2011, Cancer genomics & proteomics.

Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer

Thomas Zander, Andrea Hofmann, Joachim L Schultze, 2011, Clinical Cancer Research.

Synthetic lethality-based targets for discovery of new cancer therapeutics.

U. Weidle, D. Maisel, D. Eick, 2011, Cancer genomics & proteomics.

Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection

A. Oxenius, M. Heikenwalder, J. Trebicka, 2016, Nature Immunology.

Differential splicing generates new transmembrane receptor and extracellular matrix-related targets for antibody-based therapy of cancer.

U. Weidle, D. Maisel, M. Schmitt, 2011, Cancer genomics & proteomics.

The translational potential for target validation and therapy using intracellular antibodies in oncology.

U. Brinkmann, U. Weidle, D. Maisel, 2013, Cancer genomics & proteomics.

Integrated Systems and Technologies Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD 44 Antagonist

E. Voss, D. Maisel, M. Klammer, 2012 .

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia

R. Yeh, D. Maisel, D. Dornan, 2015, Blood Cancer Journal.

Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model

E. Voss, D. Maisel, D. Laifenfeld, 2016, PloS one.

Human-protein-derived peptides for intracellular delivery of biomolecules.

U. Brinkmann, D. Maisel, Juliane Adelmann, 2012, The Biochemical journal.

An integer linear programming approach for finding deregulated subgraphs in regulatory networks

Matthias Hein, Hans-Peter Lenhof, D. Maisel, 2011, Nucleic acids research.

Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection

A. Oxenius, M. Heikenwalder, J. Trebicka, 2016, Nature Immunology.

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

E. Voss, D. Maisel, M. Klammer, 2012, Cancer research.